Learning Objectives:

• To understand the definition of surgical resectability, including the role of liver function in patients with HCC
• To understand alternative treatments including liver-directed therapies in patients with HCC
• To become familiar with treatment options for patients with advanced HCC including those with multi-focal and extra-hepatic disease
• To become familiar with options for recurrent disease.

Héber Salvador, MD, PhD, TSBCO, FSSO (BSSO President) - AC Camargo Cancer Center, Brazil
Alexander Parikh, MD, MPH, FACS, FSSO - (SSO) -East Carolina University Brody School of Medicine, USA 
Julie Hallet, MD, MSc, FRCSC, FSSO (SSO) - University of Toronto, Sunnybrook Health Services Centre, Canada
Rodrigo Pinheiro, MD, MSc (BSSO Vice President) - Hospital de Base do Distrito Federal, Brasília, Brazil

Andre Luis de Godoy, MD (BSSO) -A.C. Camargo Cancer Center, Brazil
Marcio Boff, MD (BSSO) -Mãe de Deus Hospital, Brazil
Jorge Lyra, MD (BSSO) – Hospital das Clínicas de Imperatriz, Brazil
Katherine E. Poruk, MD (SSO) - Cancer Treatment Centers of America, USA
Adam Yopp, MD (SSO) - UT Southwestern Medical Center, USA

Victor Hugo Fonseca de Jesus -Grupo Oncoclínicas, Brazil 
Grainne O’Kane , MD - University of Toronto, Canada